3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting researcher attention due to sparse data suggesting different physiological properties. Preliminary analyses demonstrate that 3-hydroxypiperidine 3-HPC may display separate responses on the brain system, possibly contributing to some of the unexpected symptoms